BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Safety Information for the DALI LDL apheresis therapy, Fresenius

Product group Injections / Infusions / Transfusions / Dialysis - therapeutic apheresis procedures
Reference 00802/12

The manufacturer Fresenius specifies the contra indications for the DALI LDL apheresis therapy.

Safety Information for the DALI LDL apheresis therapy, Fresenius , Download_VeroeffentlichtAm_EN PDF, 64KB, File does not meet accessibility standards